Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7615 Download: 63 Web of Science: 2 Crossref: 2

Case Report

Concurrent hepatic adenomatoid tumor and hepatic hemangioma: a case report

Ji-Beom Kim, Eunsil Yu, Ju-Hyun Shim, Gi-Won Song, Gwang Un Kim, Young-Joo Jin, Ho-Seop Park

Clin Mol Hepatol. 2012;18(2):229-234. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.229

View: 5992 Download: 74 Crossref: 3

Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report

Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee

Clin Mol Hepatol. 2012;18(1):84-88. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

View: 6668 Download: 53 Crossref: 8

1 |

Viewed By 5133	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4992	MAFLD: How is it different from NAFLD?
Viewed By 4889	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3594	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3564	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search